Navigation Links
Nektar in Medical News

Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results

...Scaife has previously served as Senior Vice President of Global Safety, Regulatory Affairs and Quality for Chiron Biopharma, and in similar roles with nektar Therapeutics, Elan Pharmaceuticals and Novartis Biopharma. Jay Hagan as Senior Vice President of Corporate Development and Strategy. Jay has ...

West Announces Second Quarter 2009 Results

...d $6.6 million of pre-tax income under a contract settlement agreement with nektar Therapeutics. That agreement provided for the reimbursement of the Company'...ncome): Under a February 2008 agreement reached with our former customer, nektar Therapeutics, we received full reimbursement for, among other things, sever...

Nektar Announces UCB's Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis

... nektar Advanced Polymer Conjugate Technology Used in Cimz...RANCISCO, Calif., May 14 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) confirmed today UCB...ge. Under the terms of the agreement between nektar and UCB,...

Nektar Therapeutics to Present at the Deutsche Bank 34th Annual Health Care Conference in Boston

...N CARLOS, Calif., May 12 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) is scheduled to pre...Investor Relations, Events Calendar section of the nektar website: http://www.nektar.com . This Webcas...ilable for replay until June 10, 2009. About nektar ...

West Announces First Quarter 2009 Results

... included $1.3 million of pre-tax income from the settlement agreement with nektar Therapeutics, which provided for the reimbursement of the Company's costs o...ncome): Under a February 2008 agreement reached with our former customer, nektar Therapeutics, we received full reimbursement for, among other things, sever...

Nektar to Announce Financial Results for the First Quarter of 2009 on Wednesday, May 6, 2009, After Close of U.S.-Based Financial Markets

...CARLOS, Calif., April 29 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) will announce its f...he home page and Investor Relations section of the nektar website: http://www.nektar.com . The web broa...de available on the Investor Relations page at the nektar website as soon as practical after the conclusion ...

NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACR

...CARLOS, Calif., April 22 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) presented data toda... tumo r docetaxel exposure." About nektar nektar Therapeutics is a biopharmaceutical company develo...

Dosing Begins in Phase 1 Clinical Study Evaluating NKTR-105 in Cancer Patients With Refractory Solid Tumors

... CARLOS, Calif., Feb. 17 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) announced today tha...ur team at START is extremely pleased to work with nektar on the first clinical trial of NKTR-105 in cancer ...are in excess of $2 billion. In October 2008, nektar Therapeutics presented positive preclinical data f...

Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results

...ths ended September 30, 2008. "The turnaround at nektar is now largely complete," said Nektar President an...ed insulin collaboration by Pfizer in late 2007. nektar has continued to make significant improvements to ... approximately $66.0 million of new investments in nektar preclinical and clinical development programs. ...

West Announces Third Quarter 2008 Results

...of restructuring costs, a contract settlement with nektar Therapeutics, and discrete tax benefits recognized.... A first-quarter 2008 settlement agreement with nektar Therapeutics provided for the reimbursement of the...ments and a final settlement payment made to us by nektar net of costs incurred. We plan to convert the exis...
Nektar in Medical Technology

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

...N CARLOS, Calif., Aug. 4 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) today reported its ...per share in the second quarter of 2008. nektar made improvements to its operating efficiencies as...09 is approximately $27.4 million of investment in nektar preclinical and clinical development programs. ...

Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)

... CARLOS, Calif., March 2 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) announced positive ...rm with small molecules is a major achievement for nektar and sets the stage for the future growth of our pi...009. The results of the Phase 2 study will enable nektar to evaluate the drug in Phase 3 pivotal trials in ...

Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)

...ly- characterized K-Ras mutant patient population, nektar will initiate a prospective study to evaluate the ...and clinical investigators," said Howard W. Robin, nektar President and CEO. "We've seen significant and rep...wt/page/asco . About NKTR-102 (PEG-irinotecan) nektar is developing NKTR-102, a PEGylated form of irinot...

Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)

... Time on June 2, 2008 through a link posted on the nektar website: http://www.nektar.com/wt/page/asco . A r...reet Chicago, IL 60610 About Nektar nektar Therapeutics is a biopharmaceutical company that d...Gylation and pulmonary drug development platforms. nektar PEGylation technology has enabled eight approved p...

Amikacin Inhale Shows Promising Results in Phase II Study

... - Bayer together with nektar Therapeutics present preliminary Phase II data ...swire-FirstCall/ -- Bayer HealthCare together with nektar Therapeutics (Nasdaq: NKTR ), today presented pos... developed by Bayer HealthCare in cooperation with nektar Therapeutics, combining a special liquid formulati...

Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings

...y (ASCO) 2008 Annual Meeting in Chicago, Illinois. nektar will also present its Phase 2 clinical development...ion of NKTR-102. The Phase 1 trial, sponsored by nektar Therapeutics, includes clinical sites at Translati...ktar.com/wt/page/nktr102media . About NKTR-102 nektar is developing NKTR-102, a PEGylated form of irinot...

NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting

...day. Prior Clinical Study Results for NKTR-118 nektar previously presented results from a proof-of-princ... the most common opioid-related side effects.(2) nektar PEGylation Platform nektar PEGylation technology can enhance the properties o...

Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting

...all/ -- Positive preclinical data was presented by nektar Therapeutics (Nasdaq: NKTR ) this week for its le...ctal cancer therapy in combination with cetuximab. nektar had previously announced its intention to expand t...ktar.com/wt/page/nktr102media . About NKTR-102 nektar is developing NKTR-102, a PEGylated form of irinot...

Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings

... SAN FRANCISCO, April 10 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) announced today that...l oncology conferences this year. About Nektar nektar Therapeutics is a biopharmaceutical company that d...d pulmonary drug development technology platforms. nektar PEGylation and pulmonary technology, expertise, ma...

Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients

...nd CEO of Nektar. "Fortunately, over the past year nektar has significantly transformed its business, moving...rietary drugs in various stages of development." nektar will cease all spending associated with its inhale...or history of cigarette smoking." About Nektar nektar Therapeutics is a biopharmaceutical company that d...
Nektar in Biological Technology

Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder

SAN CARLOS, Calif., Oct. 21 /PRNewswire-FirstCall/ -- (11:00 PM PT, Oct. 20) -- Nektar Therapeutics (Nasdaq: NKTR ) today announced that Novartis AG has agreed to acquire from Nektar specific pulmonary delivery assets, technology, and intellectual property for $115 million in cash. "This ag...

Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit

SAN CARLOS, Calif., May 22 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) announced today that Bharatt Chowrira, Ph.D., J.D. has joined the Company as Chief Operating Officer and Head of the PEGylation Business Unit. His responsibilities include overseeing and managing all aspe...

West Concludes Agreement with Nektar

- Expects to Recover Investments in Dedicated Assets - LIONVILLE, Pa., Feb. 13 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that it has concluded an agreement with Nektar Therapeutics, Inc., relating to the manufacture and assembly of comp...

Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City

... CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) is scheduled to pre...Investor Relations, Events Calendar section of the nektar website: http://www.nektar.com . This Webcast...le for replay until August 31, 2009. About nektar ...

Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets

... CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) will announce its f...he home page and Investor Relations section of the nektar website: http://www.nektar.com . The web broa...de available on the Investor Relations page at the nektar website as soon as practical after the conclusion ...

World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

...Corporation, Crucell N.V., Flamel Technologies S.A., Elan Corporation Plc, Enzon Pharmaceuticals Inc., Life Technologies Corporation, Nanosphere Inc., nektar Therapeutics, Novavax Inc., Oxonica Plc, Par Pharmaceutical Companies Inc., Starpharma Holdings Limited, and Wyeth Pharmaceuticals Inc., among others....

Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer

...N CARLOS, Calif., June 9 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) today announced the...iometrics and Data Management. Dr. Masuoka joined nektar in August 2008 as Vice President of Clinical Devel... and is board certified in Neurology. About nektar ...

Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer

...nd business development for Tercica, Inc., which was acquired by Ipsen in 2008. From February 2003 to January 2006, he was chief financial officer of nektar Therapeutics. From July 2002 until joining Nektar, Mr. Bansal was director of operations analysis at Capital One Financial and, from August 1998 to J...

Nektar Therapeutics Reports First Quarter 2009 Financial Results

...AN CARLOS, Calif., May 6 /PRNewswire-FirstCall/ -- nektar Therapeutics (Nasdaq: NKTR ) today reported its ...44 per share in the first quarter of 2008. nektar made improvements to its operating efficiencies as...linical pipeline and a proven technology platform, nektar is well-positioned to enter into strategic, high-v...

Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program

...pliance and Quality Operations at Chiron Biopharma. In addition, Dr. Scaife held the position of Vice President of Quality and Regulatory Affairs for nektar Therapeutics, Vice President of Global Regulatory Affairs for Elan Pharmaceuticals, and various regulatory and clinical development positions for Nova...
Other Tags
(Date:12/25/2014)... “Every three months the trends for evening dresses ... be one of the hottest styles in the next few ... company releases 26 A-line sweetheart evening dresses, and announces the ... “We are trying our best to help a lady to ... with affordable prices, we provide discounted delivery costs to our ...
(Date:12/25/2014)... Angeles, CA (PRWEB) December 25, 2014 The ... Dolcemaschio was created in honor of a true 9/11 ... at two film festivals including the 24 hours of Nuremberg ... Festival in Bangladesh. , Actress, screenwriter and director ... helped produce this film together with her husband, Gregory ...
(Date:12/25/2014)... December 25, 2014 Helen Harris’ RP ... Woodland Hills, California after an 8 year battle with ... Christmas Eve evening in her home in Woodland Hills ... breast cancer. , As the founder ... years, she pioneered and championed many of today's greatest ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. ... chronic illnesses can receive effective, less expensive care from a ... to a team of dedicated health care professionals, a new ... ill and need either hospitalization or a trip to the ... home clinic at the University of Texas in Houston versus ...
(Date:12/25/2014)... (HealthDay News) -- Among early stage breast cancer patients ... of one percent will eventually develop leukemia as a ... The finding comes from a review of more than ... and it suggests that the risk for developing treatment-related ... previously thought. "The frequency of bone marrow cancers ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
(Date:12/11/2014)... Dec. 10, 2014  That blood pressure plays a role ... Hypertension – the medical term for high blood pressure – ... and the inflatable cuff that,s used in measuring blood pressure ... there,s nothing new about hypertension, its triggers and its effects. ... the condition and the best ways to treat it. ...
(Date:12/10/2014)... -- You,ve been here before: you desperately need to sign ... site key or the answer to your secret question. What,s ... Today, Hoyos Labs , a digital infrastructure ... put an end to the frustration that comes with usernames, ... leverages a user,s smartphone to acquire his or her biometrics ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
Other Contents